Geron Corp (NAS:GERN)
$ 4.12 -0.05 (-1.2%) Market Cap: 2.49 Bil Enterprise Value: 2.24 Bil PE Ratio: 0 PB Ratio: 8.49 GF Score: 35/100

Geron Corp at Needham Healthcare Conference (Virtual) Transcript

Apr 20, 2023 / 02:15PM GMT
Release Date Price: $2.51 (+0.80%)
Gil Blum
Needham & Company, LLC - Analyst

Good morning, everyone, and thank you for joining us at the fourth day of the Needham & Company healthcare conference. My name is Gil Bloom, and I'm a senior biotech analyst here at Needham & Company covering the immuno-oncology and gene therapy subsectors.

It is my pleasure to have with me today Chip Scarlett, the CEO of Geron. So as a reminder, any viewers who are watching through our conference portal are able to submit a question through the ask-a-question box below the video feed window.

So Chip, you said you were going to have some comments ahead. I will give you the stage.

Chip Scarlett
Geron Corporation - Chairman of the Board, President, & CEO

Okay, great. Well, first, I have to do the forward-looking statement here. So if you would pop that up, Olivia, thanks.

So during the course of this chat will be forward-looking statements regarding future events, performance, plans, expectations, and other projections including those relating to the therapeutic potential

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot